In his new role, Dickason will be responsible for guiding Board Developer clients through financial strategy and planning. Dickason’s extensive experience in finance and banking brings a unique perspective to organizations seeking to achieve financial success. Having coached and advised numerous organizations, he will use his vast knowledge to enhance future financial success. In addition, he offers a unique approach to hiring and to managing expectations of personnel. He understands that organizations hire people based on their resumes and fire them based on their ability to get along with others. He knows that fitting not only the job description but also the role and culture can significantly reduce attrition within organizations.
“Board Developer is thrilled to have Tom join the team,” said Jim Hayden, Founder and CEO of Board Developer. “His expertise and experience will elevate the organization even further. When I first met Tom and learned about his professional background, I was struck by his wealth of knowledge and experience. Tom’s distinct ability to offer strategic advice to organizations, particularly with regards to financial management, is unparalleled. I’m delighted to have him on our team as we continue to expand and offer more comprehensive services at Board Developer.”
Board Developer specializes in assembling advisory boards and boards of directors to provide organizations with access to a broad range of services and advisors to attain desired growth. For more information about Board Developer, visit boarddeveloper.com.
About Board Developer Board Developer provides business enhancement and professional development services to for-profit and nonprofit organizations and leaders. Board Developer’s broad areas of expertise are long-term strategic plans, financial reviews, governance reviews, enterprise risk management, disaster recovery plans, supply chain strategy, mergers & acquisitions, and international business expansion and management. The professional staff of Board Developer has more than 30 years of experience in corporate board leadership and development, board member placement and advanced leadership development.
MISSION VIEJO, Calif., Sept. 15, 2023 /PRNewswire/ — Over 10,000 people are missing after Storm Daniel tore through Libya on September 10th, triggering deadly flooding. More than 11,000 people have been confirmed dead, with the number expected to rise. International charity, Human…
Dr. Careaga holds a rare double board certification in plastic surgery. With the experience of over 8,000 successful operations performed, Dr. Careaga knows beauty and what his patients want.
“I don’t believe in cookie-cutter surgery. Each patient has a different body and face style and different goals in mind. By actively involving them in the process, I can consistently deliver the best possible result.” – Daniel Careaga, M.D.
PAUL DURAND, M.D.
Dr. Paul D. Durand is a Cleveland Clinic-trained plastic and reconstructive surgeon specializing in procedures of the face and body. Born in Miami and raised in Peru, he obtained all his medical education and training in the United States. Dr. Durand has maintained close ties to his hometown of Lima, which inspired a passion for international mission work in South America, completing his seventh cleft surgery mission trip last year.
Dr. Durand completed a fellowship in Aesthetic Plastic Surgery at the Dallas Plastic Surgery Institute, considered the top program in the nation for cosmetic surgery. Since then, Dr. Durand has gained extensive recognition in both plastic and reconstructive surgery and has presented and published on numerous topics, including invitations to lecture and perform live surgical demonstrations in Latin America and Asia.
Dr. Durand is licensed to practice in the states of Florida, Texas, and Ohio.
REANA MYERS, MMS, PA-C
Reana Myers is a board-certified physician assistant specializing in aesthetic medicine. She was born in Tirana, Albania, and moved to the United States when she was young. After obtaining a master’s degree in medical science from Nova Southeastern University in 2007, Reana started her career in cardiovascular medicine before transitioning into the field of plastic surgery. She has over 10 years of experience in the medical field. Reana’s professional interests include injectables such as Botox and Dysport, as well as facial fillers such as Juvederm, Voluma, Restylane, Sculptra, Radiesse, etc. She is skilled and knowledgeable in various other non-surgical treatments such as CO2, fractional, IPL, SculpSure lasers, microneedling, PRP, sclerotherapy, and weight loss. Reana is board-certified by the National Commission on Certification of Physician Assistants and is licensed to practice and prescribe in the State of Florida.
“There is beauty in everyone. That is why my goal is to enhance your beauty naturally and safely.” – Reana Myers, PA-C, MMS
WHY CHOOSE CAREAGA PLASTIC SURGERY?
Careaga Plastic Surgery is a state-of-the-art facility that has gained a reputation for being a phenomenal plastic surgery and medspa practice that utilizes the latest and most innovative technology in the industry. This modern facility specializes in a variety of procedures such as breast augmentation, breast lift, body contouring, tummy tuck, and non-surgical procedures, making Careaga Plastic Surgery the best place to start your beauty journey.
Careaga Plastic Surgery, where safety meets luxury, holds the coveted Gold Seal from the Joint Commission (JCAHO). Dr. Careaga has been voted among the top five plastic surgeons in Florida by his patients and peers for five years in a row. Careaga Plastic Surgery is where patients go to be their own masterpiece!
Haute Beauty is affiliated with the luxury lifestyle publication Haute Living. As a section of Haute Living magazine, Haute Beauty covers the latest advancements in beauty and wellness, providing readers with expert advice on aesthetic and reconstructive treatments through its network of acclaimed doctors and beauty experts.
ORLANDO, Fla., Sept. 15, 2023 /PRNewswire/ — Renowned dental experts Dr. Jedediah Huss and Julieanne O’Connor are set to co-host the highly anticipated American Dental Institute 2023 dental conference, “Secrets of the Most Influential Dental Practices” on December 8th and 9th, 2023, at…
SILVER SPRING, Md., Sept. 15, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration announced it is taking new steps to further modernize its approach to evaluating and supporting the development of innovative animal and veterinary products, to increase regulatory flexibility,…
“We are thrilled that Dr. Rahadwa is joining the Shearwater team while the severity of the global nursing shortage continues,” said Tom Kendrot, chief executive officer, Shearwater Health. “Dr. Rahadwa’s significant experience and leadership within the provider market will be a valuable addition to the Shearwater team, allowing us to help reshape how nurses and clinicians are deployed within the healthcare space to achieve productivity and efficiency.”
Nashville-based Shearwater Health has trained and augmented care teams with remote and onsite clinicians since 1973, reducing the strain on the healthcare system. With a global workforce of more than 4,000 expertly trained, clinical resources supported by innovative technology and Six Sigma process excellence, Shearwater Health offers both remote and onsite clinical expertise that can be deployed rapidly and securely. The organization recruits and trains nurses in skills such as utilization management, care management, patient care, and revenue cycle and supports their careers through education including the US Nursing Licensure Exam.
Dr. Rahadwa echoed this sentiment, expressing her gratitude and excitement to join the Shearwater family. “I am truly honored and delighted to join Shearwater Health, a company renowned for its dedication to quality and innovation in the healthcare space. I look forward to working closely with Tom and other visionary leaders along with the amazing team towards improving healthcare outcomes, further propelling the organization to new heights!”
As Shearwater Health continues to carve out its place as a leader in the healthcare industry, the inclusion of Dr. Rahadwa is a testament to the company’s commitment to attracting the best talent to serve its mission.
The team at Shearwater Health warmly welcomes Dr. Rahadwa and is eager to witness the transformative contributions she is bound to make in her new role.
About Shearwater Health
Shearwater Health provides teams of remote and onsite clinicians that expand the size and impact of clinical teams so that clients can focus on internal teams practicing at the peak of their license. From bedside to back-office, there are over 4,000 Shearwater clinicians solving medical and administrative problems every hour of every day all over the world. Shearwater combines clinical expertise with Six Sigma process excellence and RPA technology to improve healthcare outcomes. For more information, please visithttps://shearwaterhealth.com/ or on Linked In
Media Contact
Heather Rivenburg, Punching Nun Group, 1 703-216-3893, [email protected], Punching Nun Group
TCPA Staff Recognized with Medical Director of the Year and Quality Champion Awards
ATLANTA, Sept. 15, 2023 /PRNewswire-PRWeb/ — Today, TCPA, one of the largest provider groups in Georgia that partners with skilled nursing facilities and senior-living communities to deliver in-home care for elderly patients, announced its staff had received the Medical Director of the Year and Quality Champion Awards by the Georgia Medical Directors Association – The Society for Post-Acute and Long-Term Care Medicine (GMDA).
GMDA accepts nominations and gives these awards annually. The Medical Director of the Year Award is given to the Certified Medical Director who demonstrates exceptional leadership in the nursing centers that he or she serves while the Quality Champion award is given to the individual who is most committed to promoting quality care for long-term care residents.
This year, Dr. Amar Mohan, Founder and CEO of TCPA, was recognized as the Medical Director of the Year while Dawn Coffee, NP, was recognized as the Quality Champion of the Year. It marks the first time in GMDA’s history that both awards were given to members from the same organization.
“Congratulations to TCPA on this accomplishment,” said Perry Kemp, Executive Director of TCPA. “They have established systems that highlight areas of concern and areas of accomplishment in nursing home care. They maintain a high expectation of improvement continually from his centers and teach them how to improve.”
“We are incredibly honored to receive both the Georgia Medical Director of the Year Award and the Quality Champion Award from the Georgia Medical Directors Association,” said Amar Mohan, MD, Founder and CEO of TCPA. “These awards are a testament to the hard work, dedication, and unwavering commitment of our entire team. We remain steadfast in our mission to provide the highest quality healthcare services to our community.”
The Georgia Medical Directors Association (GMDA) is dedicated to advancing the practice of post-acute and long-term care medicine in Georgia. Each year, the GMDA recognizes outstanding individuals and organizations that have demonstrated exceptional leadership, innovation, and dedication to quality healthcare.
About TCPA
TCPApartners with leading skilled nursing facilities and assisted living facilities to improve healthcare transitions and long-term care. TCPA’s unique, team-based care model complements primary care, maximizes care coordination, and enables early identification and response to healthcare risks. Our approach improves clinical outcomes, reduces healthcare costs, and enables our providers to develop meaningful personal relationships with their patients and focus on proactive, whole-person care. For more information, please visit http://www.tcpamd.com.
DUBLIN, Sept. 15, 2023 /PRNewswire/ — The “Aortic Aneurysm Global Market Report 2023” report has been added to ResearchAndMarkets.com’s offering. The global aortic aneurysm market is poised for robust growth, with projected revenues surging from $3.15 billion in 2022 to $3.41 billion in…
“The FDA heard courageous testimony about the toll this disease takes on patients, about the need for improved diagnostic and screening processes, and about the lengths caregivers are going to support the health of their loved ones. Above all, they heard about the urgent need for an approved treatment. Families are doing everything they can with the resources at their disposal, but this is a devastatingly progressive disease. As we work together to make an approved PDCD treatment a reality, it’s vital the process reflects that urgency,” said UMDF President and Chief Executive Officer Brian Harman.
“We thank the FDA for the opportunity to help their staff understand the PDCD community’s experiences and perspectives. It’s crucial that we continue to lift up the voices of expertise – patients, families, clinicians, and researchers – in forums like this,” he added.
Said MitoAction Chief Executive Officer Kira Mann: “As the patient-centered patient advocacy organization, we stand committed to fostering a space where the voices of those affected by mitochondrial diseases like PCDC can resonate. Just as we are dedicated to amplifying these voices, we also acknowledge the paramount significance of empowering patients and caregivers with knowledge about the FDA regulatory process. As advocates, we aim to empower individuals with the tools they need to actively engage in this critical process and ensure their voices are heard, because when patients are informed and engaged, they become a driving force for progress.”
UMDF and MitoAction thank the PDCD community members who bravely shared their stories and the many patient advocacy groups that helped make the listening session a success including Hope for PDCD and The Elizabeth Watt PDCD Research Fund.
Six caregivers to PDCD patients (one of whom is also an affected adult) participated in the FDA videoconference, along with clinician Rebecca Ganetzky, MD, of Children’s Hospital of Philadelphia.
Amongst the testimony heard was Emma, whose daughter Elizabeth is a 20-year-old patient with PDCD.
“As a family, we have lived in a crisis mode for the past 20 years. Constantly worried about death. We have already watched her regress medically and physically, and we fear that every illness will be the one that ends her life. Even minor illnesses can be catastrophic, so we live all day every day in fear. The sad fact is there is not a definitive treatment for PDCD,” she said. “Collectively, we come here today to ask for the hope that all people diagnosed with PDCD will be able to live a long and fulfilling life.”
This was the second FDA Listening Session UMDF and MitoAction have cohosted for a mitochondrial disease in the last 20 months. In January 2022, the FDA held a similar session for thymidine kinase 2 deficiency (TK2d), another rare mitochondrial disease.
ABOUT PYRUVATE DEHYDROGENASE COMPLEX DEFICIENCY
Pyruvate Dehydrogenase Complex Deficiency (PDCD) is a rare mitochondrial disorder that causes impaired carbohydrate metabolism, resulting in neurological problems and a buildup of a chemical called lactic acid in the blood. PDCD is caused by mutations in the genes that make up or affect the activity of the PDC, which is located in the mitochondria that make almost all the energy we need to survive. Nearly all individuals with PDCD experience developmental delay, poor muscle tone, and brain cell loss, which are often accompanied by a host of other issues. Like all mitochondrial diseases, there is currently no FDA-approved treatment or cure for PDCD.
ABOUT THE UNITED MITOCHONDRIAL DISEASE FOUNDATION
Founded in 1996, the United Mitochondrial Disease Foundation (UMDF) works to promote research and education for the diagnosis, treatment and cure of mitochondrial diseases and to provide support for affected individuals and families. Since its inception, the UMDF has funded more than $15 million in research, making it the leading non-governmental contributor of grants focused solely on mitochondrial disease. Every year, UMDF provides support and education to thousands of patients and medical professionals across the globe. Learn more at umdf.org.
ABOUT MITOACTION
Since 2005, MitoAction has transformed the lives of families affected by mitochondrial disease. Our mission is to improve the quality of life for children, adults, and families living with mitochondrial disease through support, education, outreach, advocacy, clinical research initiatives, and granting wishes for children affected by mitochondrial disease. Committed to making the largest impact possible, MitoAction serves individuals in the U.S. and worldwide through support, education, outreach, advocacy, and clinical research initiatives. The programs and services MitoAction provides continue to be a lifeline for families impacted by mitochondrial disease. Families know with MitoAction, they will never be alone on this difficult journey. Learn more at mitoaction.org.
From its inception, the organization has aimed to redefine mental health care standards by ensuring that every student-athlete receives the support they deserve. Taking a proactive approach, CBHA bridges the gap created by the stigma and hesitations often associated with seeking mental health assistance ensuring that every licensed professional has the necessary time to work with athletes that can lead to proper, long-term solutions.
Steve Wigginton, the Chief Executive Officer of CBHA, added to the company’s vision of being one of the top 5 mental health providers in the world by providing care to 100,000 to 200,000 patients per year. “We recognize the urgent need for change in the mental health care landscape,” Wigginton stated, “and we are dedicated to making that change happen. While our current priority is supporting athletes, our long-term vision includes expanding our services to reach the entire student body and all other entities in need of comprehensive mental health care within the United States. This is the transformation mental health care needs in this country.”
CBHA’s groundbreaking efforts are paving the way for a brighter future where mental health care is accessible, comprehensive, and compassionate, starting with college athletes.
